The United States represents the largest share of the North American lacrimal duct stent tube market owing to its high healthcare expenditure, strong adoption of innovative ophthalmic devices, and increasing number of ophthalmic surgeries performed annually. The rising incidence of congenital and acquired lacrimal duct obstructions, coupled with growing awareness among patients regarding early...